MRS2-C Antibody

What epitopes are targeted by commercial MRS2 antibodies?

Commercial MRS2 antibodies target various epitopes across the protein. For example, one common antibody targets amino acids 211-223 of rat MRS2 (sequence (C)DPKHSSVDRSKLH), located at the N-terminus in the mitochondrial matrix . Other antibodies target the middle region or amino acids 215-264, with varying species reactivity . When selecting an antibody, researchers should consider the conservation of the target epitope across species relevant to their research.

How can I confirm MRS2 antibody specificity in my experimental system?

Antibody specificity can be confirmed through multiple approaches:

• Western blot analysis with preincubation blocking peptide controls

• Comparison of expression patterns in tissues known to express MRS2 (e.g., hippocampus)

• Use of knockout/knockdown controls

For example, immunohistochemical staining of mouse hippocampus shows MRS2 immunoreactivity in the pyramidal layer, which can be suppressed by preincubation with blocking peptide . Similarly, western blot analysis of rat testis, kidney, and heart lysates shows specific bands that disappear after preincubation with blocking peptide .

What applications are MRS2 antibodies validated for?

MRS2 antibodies have been validated for multiple applications:

When using these antibodies, researchers should optimize conditions for their specific experimental system .

How can MRS2 antibodies be used to distinguish between glycosylated and non-glycosylated MRS2 isoforms?

Recent research has revealed that MRS2 exists in both N-glycosylated and non-glycosylated states in mammalian mitochondria. To distinguish between these isoforms:

• Perform western blot analysis of mitochondrial fractions, looking for the characteristic double banding pattern

• Confirm glycosylation status by treating samples with peptide:N-glycosidase F (PNGase F) and observing gel shift of the higher molecular weight band

• Use lectin affinity columns (concanavalin A or Lens culinaris agglutinin) followed by western blotting to selectively isolate glycosylated forms

This approach has been validated in multiple cell lines including mouse liver, rat and mouse liver fibroblast cells (BRL 3A and AFT024), and human skin fibroblasts . The glycosylation status of MRS2 appears to correlate with cellular energy metabolism, with changes in the glycosylation pattern observed when cells are forced to rely on mitochondrial respiration .

How can MRS2 antibodies help investigate structure-function relationships in this channel protein?

MRS2 antibodies can be powerful tools for investigating structure-function relationships:

• Use antibodies targeting specific domains (such as the conserved F/Y-G-M-N motif) in combination with site-directed mutagenesis

• Correlate antibody-detected expression levels with functional assays such as Mg²⁺ influx measurements

• Compare wild-type and mutant protein localization and assembly using immunoprecipitation and native PAGE

For example, research has shown that mutations in the conserved G-M-N motif (e.g., mrs2-J1 G998→C998) dramatically reduce Mg²⁺ influx capacity while maintaining protein expression and stability . Antibodies can be used to confirm equal expression levels of wild-type and mutant proteins in such experiments.

What technical approaches can resolve contradictions in MRS2 mitochondrial targeting sequence identification?

Conflicting reports exist regarding the exact cleavage site of the mitochondrial targeting sequence (MTS) in MRS2. To resolve this:

• Use N-terminal sequencing of purified human MRS2 (which identified residue 71 as the first amino acid after cleavage)

• Compare with prediction software results (which gave varying results: not detected by Target-2.0 and SignalP-6.0, predicted at residue 21 by Mitofates, and at residue 50 according to Uniprot)

• Validate experimentally using GFP fusion constructs with full-length or truncated (71-443) MRS2

Confocal microscopy showed that full-length MRS2-GFP localizes to mitochondria, while MRS2(71-443)-GFP localizes primarily to the ER, confirming the importance of the N-terminal sequence for proper targeting . This methodological approach can help researchers resolve similar contradictions in their studies.

How should researchers design experiments to study the relationship between MRS2 expression and mitochondrial Mg²⁺ influx?

To properly investigate MRS2's role in mitochondrial Mg²⁺ homeostasis:

• Combine immunodetection (using anti-MRS2 antibodies) with functional assays using Mg²⁺-sensitive fluorescent dyes (e.g., mag-fura 2)

• Create experimental conditions with varying MRS2 expression levels (knockout, wild-type, overexpression)

• Measure both resting [Mg²⁺]ₘ and influx rates in response to external [Mg²⁺] changes

Research has demonstrated that overexpression of MRS2 increases Mg²⁺ influx rates 5-fold compared to wild-type, while deletion of the MRS2 gene abolishes this high-capacity Mg²⁺ influx . Interestingly, steady-state plateau levels of [Mg²⁺]ₘ reached after increasing external [Mg²⁺] were only slightly higher than wild-type values, suggesting complex regulatory mechanisms that antibody-based studies could help elucidate .

What controls are essential when using MRS2 antibodies in mitochondrial fractionation studies?

When using MRS2 antibodies in subcellular fractionation experiments, include:

• Mitochondrial markers (e.g., VDAC, cytochrome c) to confirm mitochondrial enrichment

• ER markers (e.g., calnexin) to assess contamination from closely associated membranes

• Cytosolic markers to confirm effective fractionation

• Protease protection assays to confirm submitochondrial localization

These controls are particularly important given that MRS2's localization to the inner mitochondrial membrane is critical for its function, and that mislocalized truncated versions (e.g., MRS2(71-443)) can localize to the ER instead of mitochondria .

How can researchers use MRS2 antibodies to investigate its role in disease models?

MRS2 antibodies can be valuable tools for investigating disease mechanisms:

• Quantify MRS2 expression levels and glycosylation status in patient-derived cells or tissues

• Correlate with functional assays of mitochondrial magnesium transport

• Perform co-immunoprecipitation studies to identify altered protein interactions

For example, researchers have observed that the N-glycosylated MRS2 isoform is increased in several mitochondrial respiratory chain disease patient fibroblast cell lines . This suggests that alterations in MRS2 glycosylation may be part of a cellular adaptation mechanism in mitochondrial disorders. Similarly, MRS2's role in proper myelination of the central nervous system indicates potential relevance to neurological disorders .

How can researchers address sample preparation challenges when detecting MRS2 in different tissues?

MRS2's mitochondrial localization presents specific challenges:

• Use differential centrifugation followed by density gradient purification to isolate high-purity mitochondria

• Consider detergent solubilization conditions carefully (MRS2 is an integral membrane protein)

• For fixed tissue samples, optimize fixation conditions to preserve epitope accessibility

For example, immunohistochemical detection of MRS2 in mouse hippocampus has been successful using perfusion-fixed frozen brain sections , while biochemical studies typically require isolated mitochondria with specific solubilization conditions to maintain protein integrity.

What approaches can help characterize novel MRS2 interaction partners using antibody-based techniques?

To identify and validate MRS2 interaction partners:

• Perform co-immunoprecipitation using anti-MRS2 antibodies followed by mass spectrometry

• Validate potential interactions with reverse co-immunoprecipitation

• Use proximity ligation assays to confirm interactions in situ

• Consider chemical crosslinking approaches to stabilize transient interactions

This approach could help identify proteins involved in the assembly of the pentameric MRS2 channel or regulatory partners that modulate its activity. Recent structural studies have revealed that MRS2 forms symmetrical pentamers with specific features like the Cl⁻-bound R-ring, which consists of five Arg332 residues . Antibody-based approaches could help elucidate how this assembly is regulated in different physiological contexts.

How might MRS2 antibodies contribute to understanding the relationship between magnesium homeostasis and energy metabolism?

Recent findings indicate that N-glycosylation of MRS2 correlates with the relative contributions of oxidative phosphorylation and glycolysis to cellular energy demands . To investigate this relationship:

• Use MRS2 antibodies to monitor glycosylation status in cells with different metabolic profiles

• Combine with functional assays of both magnesium transport and energy metabolism

• Explore potential signaling pathways connecting metabolic state to MRS2 modification

This approach could help uncover the molecular mechanisms by which cells adapt mitochondrial magnesium transport to changing energy demands, with potential implications for understanding metabolic disorders and developing therapeutic strategies.

What methodological approaches can help investigate the role of MRS2 in specialized secretory cells?

Proteogenomic analysis has identified MRS2 as potentially relevant in antibody-secreting cells . To investigate this connection:

• Use anti-MRS2 antibodies to compare expression and localization in naïve B cells versus plasma cells

• Examine MRS2 glycosylation status during B cell differentiation

• Correlate MRS2 expression/modification with secretory capacity

This approach could help determine whether mitochondrial magnesium homeostasis plays a specialized role in supporting the high energy demands and calcium signaling requirements of professional secretory cells.